GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
B

Baolingbao Biology Co 002286.SZ · CNY

Consumer Staples · Shenzhen · 🇨🇳 China

Compare

8.51

-2.96%

Close of 9 Nov 2026, in CNY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Baolingbao Biology Co

Its shares trade on Shenzhen under the ticker 002286.SZ. It has been listed since 11 August 2009. In the fiscal year to 31 December 2025, it reported revenue of CN¥2.75bn and net income of CN¥150.6m. At that date it held total assets of CN¥2.78bn and shareholders' equity of CN¥2.23bn.

Baolingbao Biology Co., Ltd. engages in the manufacture of all kinds functional sugar. The company is headquartered in Dezhou, Shandong. The company went IPO on 2009-08-11. The firm mainly provides oligosaccharide series, sugar alcohol series, high fructose syrup series, other starch sugar series, as well as starch and byproducts. The firm distributes its products in domestic markets and to overseas markets.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Consumer Staples
Industry
Food Products
Listed since
11 Aug 2009
Employees
1,323
Website
blb-cn.com ↗

Leadership

Pay as last reported

  • Mr. Sijue DaiChairman of the Board, since 2021
  • Mr. Hongbo LiVice Chairman of the Board, since 2019
  • Mr. Yanjun WangChief Financial Officer, Deputy General ManagerCN¥225,000
  • Mr. Qiang WangGeneral Manager, Director, since 2023
  • Xia LiDeputy General Manager, Acting Secretary of the Board
  • Mr. Feng LiuExecutive Deputy General Manager, Director, since 2014CN¥280,000
  • Facai LiDeputy General Manager
  • Yumin SongDeputy General Manager
  • Mr. Cuiping QinDirector
  • Mr. Jun FangIndependent Director
  • Mr. Huaxiao XiaoIndependent Director
  • Ms. Xiaolian ZhaoIndependent Director

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Baolingbao Biology produces oligosaccharide series for health benefits in China.
  • The company distributes starch sugar series to domestic and overseas markets effectively.
  • Baolingbao Biology employs 1,323 full-time staff in Dezhou, Shandong.

Weaknesses

  • Baolingbao Biology's product range lacks innovation in functional sugar development.
  • The company has limited international market presence beyond domestic distribution.
  • Baolingbao Biology's business is concentrated in the Consumer Staples sector.

Opportunities

  • Expanding oligosaccharide series into the Health Care industry market.
  • Increasing high fructose syrup series exports to overseas markets.
  • Growing demand for starch sugar series in the Food Products industry.

Threats

  • Competition from other Food Products companies in China.
  • Regulatory changes affecting sugar products in the Consumer Staples sector.
  • Economic downturns impacting domestic market sales in China.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.